Generic Name: cyclosporine
Brand Name: Verkazia
Manufacturer: Santen Inc.
Indications: Severe vernal keratoconjunctivitis, pediatric (≥4 years)
Manufacturer Requested Reimbursement Criteria1:
For the treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age through adolescence.
Submission Type: New
Project Status: Pending
Call For Patient Input: April 23, 2019
Patient Input Closed: June 12, 2019
Anticipated Date: May 22, 2019
Fee Schedule: Pending
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.